Andere Sprachen Rakovina Therapeutics Inc.

Aktien

A3DJYB

CA75103L1013

RKV

Markt geschlossen - Toronto S.E. Andere Börsenplätze 16:54:38 26.04.2024			% 5 Tage	% 1. Jan.
0.09 ^CAD	0.00%		0.00%	+5.88%

09.04.	Rakovina Therapeutics präsentiert auf der Jahrestagung der American Association of Cancer Research	MT
2023	Rakovina Therapeutics gibt Ernennung zum wissenschaftlichen Beirat bekannt	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Rakovina Therapeutics Inc. Announces 2023 Financial Results and Provides Corporate Update	02:39
Rakovina Therapeutics Presents At American Association Of Cancer Research Annual Meeting	09.04.
Rakovina Therapeutics Presented at American Association of Cancer Research Annual Meeting at the San Diego Convention Center Today	09.04.
Accelerating New Molecule Discovery: Rakovina Therapeutics AI Integration	02.04.
Rakovina Therapeutics To Host Informational Webinar on April 3, 2024	01.04.
Rakovina Therapeutics Announces Strategic Pivot to AI	27.03.
Rakovina Therapeutics Inc. Announces Q3 2023 Financial Results and Provides Corporate Update	28.11.
Rakovina Therapeutics Announces Appointment to Scientific Advisory Board	27.11.
Rakovina Therapeutics Welcomes Prof. Artem Cherkasov to the Company’s Scientific Advisory Board	27.11.
Rakovina Therapeutics Welcomes Prof. Artem Cherkasov to the Company’s Scientific Advisory Board	27.11.
Rakovina Therapeutics Appoints Prof. Artem Cherkasov to the Scientific Advisory Board	27.11.
Rakovina Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	27.11.
Rakovina Therapeutics Announces Appointment of New Scientific Advisory Board Member	20.11.
Rakovina Therapeutics Inc. Announces Appointment of Prof. Petra Hamerlik as New Scientific Advisory Board Member	20.11.
Rakovina Therapeutics continues to make progress as company provides corporate update	13.09.23
Rakovina Therapeutics Inc. Announces Q2 2023 Financial Results and Provides Corporate Update	29.08.23
Rakovina Therapeutics Inc. Announces Q2 2023 Financial Results and Provides Corporate Update	29.08.23
Rakovina Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	29.08.23
Rakovina Therapeutics Announces Results from 2023 Annual General Meeting	29.06.23
Rakovina Therapeutics Inc. Announces Q1 2023 Financial Results and Provides Corporate Update	31.05.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Rakovina Therapeutics Inc.

Aktien

A3DJYB

CA75103L1013

RKV

Andere Sprachen

Filter